We are live on
!
Find out more
ORIAW
Orion Biotech Opportunities Corp. Warrant
ORIAW
ORIAW
Delisted
ORIAW was delisted on the 28th of April, 2023.
29 hedge funds and large institutions have $2.25M invested in Orion Biotech Opportunities Corp. Warrant in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
3% more capital invested
Capital invested by funds: $2.18M → $2.25M (+$67.9K)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
6% less funds holding
Funds holding: 31 → 29 (-2)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Holders
29
Holders Change
-2
Holders Change %
-6.45%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
3
Calls
$561K
Puts
–
Net Calls
+$561K
Net Calls Change
+$12K
Top Buyers
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$29.3K |
| 2 |
Jane Street
New York
|
+$8.53K |
| 3 |
JFG
Jefferies Financial Group
New York
|
+$2.11K |
| 4 |
DCM
DG Capital Management
New York
|
+$39 |
Top Sellers
| 1 |
FTCM
Fir Tree Capital Management
New York
|
-$36K |
| 2 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$12K |
| 3 |
CF
Cantor Fitzgerald
New York
|
-$6.74K |
| 4 |
SC
Sculptor Capital
New York
|
-$3.68K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1K |
